94
Views
12
CrossRef citations to date
0
Altmetric
Commentary

Probiotics and prebiotics in allergy prevention and treatment: future prospects

Pages 17-19 | Published online: 10 Jan 2014

References

  • Smith K, McCoy KD, Macpherson AJ. Use of anexic animals in studying the adaptation of mammals to their commensal intestinal microbiota. Semin. Immunol.19, 59–69 (2007).
  • Labeta MO, Vidal K, Nores JER et al. Innate recognition of bacteria in human milk is mediated by a milk-derived highly expressed pattern recognition receptor, soluble CD14. J. Exp. Med.191, 1807–1812 (2000).
  • Björkstén B, Sepp E, Julge K et al. Allergy development and the intestinal microflora during the first year of life. J. Allergy Clin. Immunol.108, 516–520 (2001).
  • Kalliomäki M, Salminen S, Arvilommi H et al. Probiotics in primary prevention of atopic disease: a randomized placebo-controlled trial. Lancet357, 1076–1079 (2001).
  • Kalliomäki M, Salminen S, Poussa T et al. Probiotics during the first 7 years of life: a cumulative risk reduction of eczema in a randomized, placebo-controlled trial. J. Allergy Clin. Immunol.119, 1019–1021 (2007).
  • Kopp MV, Hennemuth I, Heinmann A et al. Randomized, double-blind, placebo-controlled trial of probiotics for primary prevention: no clinical effects of Lactobacillus GG supplementation. Pediatrics121, e850–e856 (2008).
  • Abrahamsson TR, Jakobsson T, Fågeras Böttcher M et al. Probiotics in prevention of IgE-associated eczema: a double-blind, randomized, placebo-controlled trial. J. Allergy Clin. Immunol.119, 1174–1180 (2007).
  • Taylor AL, Dunstan AJ, Prescott SL. Probiotic supplementation for the first months of life fails to reduce the risk of atopic dermatitis and increases the risk of allergen sensitization in high-risk children: a randomized controlled trial. J. Allergy Clin. Immunol.119, 184–191 (2007).
  • Rosenfeldt V, Benfeldt E, Nielsen SD et al. Effect of probiotic Lactobacillus strain in children with atopic dermatitis. J. Allergy Clin. Immunol.111, 389–395 (2003).
  • Villjanen M, Savilahti E, Haahtela T et al. Probiotics in the treatment of atopic eczema/dermatitis syndrome in infants: a double-blind placebo-controlled trial. Allergy60, 494–500 (2005).
  • Weston S, Halpert A, Richmond P et al. Effects of probiotics on atopic dermatitis: a randomized controlled trial. Arch. Dis. Child.90, 892–897 (2005).
  • Grüber C, Wendt M, Sulser C et al. Randomized, placebo-controlled trial of Lactobacillus rhamnosus GG as treatment of atopic dermatitis in infancy. Allergy62, 1270–1276 (2007).
  • Kol J, Scholtens P, Kafka C et al. Colon microflora in infants fed formula with galacto- and fructo-oligosaccharides: more like breast-fed infants. J. Pediatr. Gastroenterol. Nutr.40, 36–42 (2005).
  • Moro G, Arslanoglu S, Stahl B et al. A mixture of prebiotic oligosaccharides reduces the incidence of atopic dermatitis during the first six months of age. Arch. Dis. Child.91, 814–819 (2006).
  • Arslanoglu S, Moro GE, Schmitt J et al. Early dietary intervention with a mixture of prebiotic oligosaccharides reduces the incidence of allergic manifestations and infections during the first two years of life. J. Nutr.138, 1091–1095 (2008).
  • Vos AP, van Esch BC, Stahl B et al. Dietary supplementation with specific oligosaccharide mixtures decreases parameters of allergic asthma in mice. Int. Immunopharmacol.7, 1582–1587 (2007).
  • Grüber C, van Stuivenberg M, Mosca F et al. Reduced occurrence of early atopic dermatitis due to immunoactive prebiotics among low atopy risk infants in the randomised multicentric infection prevention study (MIPS). J. Allergy Clin. Immunol.126, 791–797 (2010).
  • Niers I, Martin R, Rijkers G et al. The effect of selected probiotic strains on the development of eczema (the PandA study). Allergy64, 1349–1358 (2009).
  • Frossard CP, Steidler L, Eigenmann PA. Oral administration of an IL-10-secreting Lactococcus lactis strain prevents food-induced IgE sensitization. J. Allergy Clin. Immunol.119, 952–959 (2007).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.